Opsona Raises €33 million

Opsona Therapeutics raised €33 million (US $ 43 million) in an oversubscribed Series C financing led by BB Biotech Ventures and Novartis Venture Fund. Other new investors included Sunstone Capital, Baxter Ventures, Amgen Ventures and EMBL Ventures. Participants included existing investors Fountain Healthcare Partners, Roche Venture Fund and Seroba Kernel Life Sciences. Opsona develops new treatments for inflammatory diseases.

North AmericaUSBriefs